• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pediatric Hodgkin Lymphoma: on the road to a 'radiotherapy-free' cure rate?-Commentary on a report on final results of the Multinational Trial GPOH-HD95.

作者信息

Corazzelli Gaetano

机构信息

Hematology-Oncology and Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS, Via Mariano Semmola, 80131 Naples, Italy.

出版信息

Transl Pediatr. 2013 Jul;2(3):120-3. doi: 10.3978/j.issn.2224-4336.2013.05.02.

DOI:10.3978/j.issn.2224-4336.2013.05.02
PMID:26835302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4728935/
Abstract
摘要

相似文献

1
Pediatric Hodgkin Lymphoma: on the road to a 'radiotherapy-free' cure rate?-Commentary on a report on final results of the Multinational Trial GPOH-HD95.儿童霍奇金淋巴瘤：迈向“无放疗”治愈率之路？——对多国试验GPOH-HD95最终结果报告的评论
Transl Pediatr. 2013 Jul;2(3):120-3. doi: 10.3978/j.issn.2224-4336.2013.05.02.
2
Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.儿童或青少年霍奇金淋巴瘤中省略或减少放疗。
Transl Pediatr. 2013 Jul;2(3):126-30. doi: 10.3978/j.issn.2224-4336.2013.06.03.
3
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.儿童和青少年霍奇金淋巴瘤患者在化疗后完全缓解时不进行放疗的治疗：多国试验 GPOH-HD95 的最终结果。
J Clin Oncol. 2013 Apr 20;31(12):1562-8. doi: 10.1200/JCO.2012.45.3266. Epub 2013 Mar 18.
4
The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphoma.中心审查和中心治疗计划对儿童和青少年霍奇金淋巴瘤治疗的影响。
Eur J Cancer. 2014 Jan;50(2):425-33. doi: 10.1016/j.ejca.2013.09.017. Epub 2013 Oct 21.
5
Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.仅在早期反应 PET 中（Deauville 5 或 qPET≥2）有强烈增强的残留 FDG 摄取与儿童霍奇金淋巴瘤的预后相关：GPOH-HD2002 试验的结果。
Pediatr Blood Cancer. 2019 Mar;66(3):e27539. doi: 10.1002/pbc.27539. Epub 2018 Nov 14.
6
Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.
Klin Padiatr. 2003 Nov-Dec;215(6):315-20. doi: 10.1055/s-2003-45498.
7
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.反应适应放疗省略与巩固化疗在中晚期经典霍奇金淋巴瘤患儿和青少年中的比较（欧洲血液与骨髓移植学会-儿童肿瘤组 Hodgkin 淋巴瘤协作组 1 期临床试验）：一项带有开放性标签、嵌入式、多国、非劣效、随机对照滴定研究。
Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 9.
8
Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial.VECOPA（一种用于中晚期霍奇金淋巴瘤儿童和青少年的剂量密集化疗方案）的可行性：GPOH-HD-2002/VECOPA 试点试验结果
Leuk Lymphoma. 2015 May;56(5):1308-14. doi: 10.3109/10428194.2014.961011. Epub 2014 Oct 9.
9
Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial.适应性放疗在儿童霍奇金病治疗中的应用：德国GPOH-HD 95试验5年中期报告
Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1209-18. doi: 10.1016/s0360-3016(01)01798-9.
10
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.基于早期对 VAMP 化疗的反应，放疗与不放疗对儿童低危霍奇金淋巴瘤患者生存的影响。
JAMA. 2012 Jun 27;307(24):2609-16. doi: 10.1001/jama.2012.5847.

引用本文的文献

1
A U.S. population-based study of insurance disparities in cancer survival among adolescents and young adults.一项基于美国人群的研究显示，青少年和年轻成年人的癌症存活率存在保险差异。
Cancer Med. 2019 Aug;8(10):4867-4874. doi: 10.1002/cam4.2230. Epub 2019 Jun 26.
2
Treatment of Hodgkin's lymphoma in childhood and adolescence without radiotherapy.儿童及青少年霍奇金淋巴瘤不采用放疗的治疗方法
Transl Pediatr. 2013 Jul;2(3):131-2. doi: 10.3978/j.issn.2224-4336.2013.07.02.

本文引用的文献

1
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.儿童和青少年霍奇金淋巴瘤患者在化疗后完全缓解时不进行放疗的治疗：多国试验 GPOH-HD95 的最终结果。
J Clin Oncol. 2013 Apr 20;31(12):1562-8. doi: 10.1200/JCO.2012.45.3266. Epub 2013 Mar 18.
2
Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?霍奇金淋巴瘤中氟代脱氧葡萄糖正电子发射断层扫描的中期结果：临床试验中安全导航的指南针？
Blood. 2012 Dec 13;120(25):4913-20. doi: 10.1182/blood-2012-03-403790. Epub 2012 Aug 28.
3
Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks.小儿霍奇金淋巴瘤：短期和长期死亡风险之间的权衡。
Blood. 2012 Sep 13;120(11):2195-202. doi: 10.1182/blood-2012-02-409821. Epub 2012 Jul 23.
4
Finding the balance in pediatric Hodgkin's lymphoma.
J Clin Oncol. 2012 Sep 10;30(26):3158-9. doi: 10.1200/JCO.2012.42.6890. Epub 2012 May 29.
5
Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group.CCG 5942 研究：儿童霍奇金淋巴瘤化疗联合或不联合放疗的随机比较——儿童肿瘤协作组的报告
J Clin Oncol. 2012 Sep 10;30(26):3174-80. doi: 10.1200/JCO.2011.41.1819. Epub 2012 May 29.
6
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.强化化疗联合 PET 引导放疗与单纯强化化疗治疗晚期霍奇金淋巴瘤（HD15 试验）：一项随机、开放标签、III 期非劣效性试验。
Lancet. 2012 May 12;379(9828):1791-9. doi: 10.1016/S0140-6736(11)61940-5. Epub 2012 Apr 4.
7
Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.儿童经典型霍奇金淋巴瘤的肿瘤微环境组成受年龄和 Epstein-Barr 病毒感染的调节。
Int J Cancer. 2012 Sep 1;131(5):1142-52. doi: 10.1002/ijc.27314. Epub 2011 Dec 21.
8
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.ABVD 方案对比 BEACOPP 方案用于计划大剂量挽救治疗的霍奇金淋巴瘤。
N Engl J Med. 2011 Jul 21;365(3):203-12. doi: 10.1056/NEJMoa1100340.
9
Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.霍奇金淋巴瘤长期幸存者的发病率和死亡率：来自儿童癌症幸存者研究的报告。
Blood. 2011 Feb 10;117(6):1806-16. doi: 10.1182/blood-2010-04-278796. Epub 2010 Oct 29.
10
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.早期霍奇金淋巴瘤患者的治疗强度降低。
N Engl J Med. 2010 Aug 12;363(7):640-52. doi: 10.1056/NEJMoa1000067.